Evidence map›Paper›PMID 17158963›Full record

ArticleThe Journal of experimental medicine2006

Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.

Sathyavageeswaran Shreeram, Weng Kee Hee, Oleg N Demidov, Calvina Kek, Hiroshi Yamaguchi, Albert J Fornace, Carl W Anderson, Ettore Appella, Dmitry V Bulavin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. The role of PPM1D in cancer and advances in studies of its inhibitors.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response.International journal of molecular sciences · 2022
    Review
  12. Cancers · 2021
    Article
  13. High Expression ofCancers · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Protein phosphatases in chromatin structure and function.Biochimica et biophysica acta. Molecular cell research · 2019
    Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Sathyavageeswaran ShreeramInstitute of Molecular and Cell Biology, Singapore, 138673.
Weng Kee Hee
Oleg N Demidov
Calvina Kek
Hiroshi Yamaguchi
Albert J Fornace
Carl W Anderson
Ettore Appella
Dmitry V Bulavin
Institute of Molecular and Cell Biology · SGBrookhaven National Laboratory · USCenter for Cancer Research · USHarvard University · USNational Institutes of Health · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

The ataxia telangiectasia mutated (ATM) kinase is a key tumor suppressor that regulates numerous cell cycle checkpoints as well as apoptosis. Here, we report that ATM is a critical player in the regulation of apoptosis and lymphomagenesis in the presence of c-myc. In turn, deletion of the inhibitory ATM phosphatase, Wip1, results in ATM up-regulation and suppression of Emicro-myc-induced B cell lymphomas. Using mouse genetic crosses, we show that the onset of myc-induced lymphomas is dramatically delayed in Wip1-null mice in an ATM- and p53-, but not p38 MAPK- or Arf-, dependent manner. We propose that Wip1 phosphatase is critical for regulating the ATM-mediated tumor surveillance network.

Indexed as

AnimalsApoptosisAtaxia Telangiectasia Mutated ProteinsBlotting, WesternB-LymphocytesCaspase InhibitorsCaspasesCell Cycle ProteinsCell ProliferationCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsGene ExpressionHeat-Shock ProteinsHSP27 Heat-Shock ProteinsLymphomaMiceAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCaspase InhibitorsCaspasesCdkn2a protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHspb2 protein, mouseNeoplasm Proteinsp38 Mitogen-Activated Protein KinasesPhosphoprotein PhosphatasesPpm1d protein, mouseProtein Phosphatase 2CProtein Serine-Threonine KinasesProto-Oncogene Proteins c-mycTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID17158963
PMCPMC2118180
OpenAlexW2158691993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.